News

New imaging promises improved breast cancer utility


 

EXPERT ANALYSIS FROM IMPAKT 2013 BREAST CANCER CONFERENCE

The conference was sponsored by the European Society for Medical Oncology.

Dr. Pinker-Domenig and Dr. Cook had no disclosures. Dr. de Vries said that she has received grant support from Genentech and Novartis.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

Weight loss, exercise can impact cancer incidence and recurrence
MDedge Hematology and Oncology
Ki-67 shows proven clinical utility as a predictive biomarker for breast cancer
MDedge Hematology and Oncology
Pulsed-dye laser erased evidence of breast radiation
MDedge Hematology and Oncology
Supreme Court ponders patenting of human genes
MDedge Hematology and Oncology
Study suggests statin use decreases breast cancer mortality
MDedge Hematology and Oncology
Smaller margins too close for comfort in breast cancer
MDedge Hematology and Oncology
Online cancer community colaunched by ex-Google executive
MDedge Hematology and Oncology
Genetic tests gauge breast-cancer recurrence risk
MDedge Hematology and Oncology
Cancer-cell reprogramming poses new treatment challenge
MDedge Hematology and Oncology
Intratumor heterogeneity drives need for multiple biopsies
MDedge Hematology and Oncology